Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Rajkumar

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Pediatrics|August 1, 1975
A chart audit peer review system in an ambulatory serviceR M Russo, V J Gururaj, T A Laude, et al.
Clinical Pediatrics|February 1, 1976
Triacetyloleandomycin in streptococcal throat infections. A reappraisal of an older antibioticV J Gururaj, R M Russo, S V Rajkumar, et al.
Leukemia|January 20, 2009
Dexamethasone and the risk for adrenal suppression in multiple myelomaA C Ng, S K Kumar, S J Russell, et al.
Leukemia|November 2, 2007
Clinically relevant end points and new drug approvals for myelomaK C Anderson, R A Kyle, S V Rajkumar, et al.
International Journal of Laboratory Hematology|April 5, 2012
A novel β-globin gene mutation HBB.c.22 G>C produces a hemoglobin variant (Hb Vellore) mimicking HbS in HPLCE S Edison, M Sathya, S V Rajkumar, et al.
British Journal of Haematology|September 16, 2009
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trialMorie A Gertz, Rafat Abonour, Leonard T Heffner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2013
Fluorescent PCR-based gene dose analysis for detection of deletion mutations in carriers of haemophiliaG Sankari Devi, N Arora, S V Rajkumar, et al.
Leukemia|February 6, 2013
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patientsL E Roeker, D R Larson, R A Kyle, et al.
Leukemia|November 28, 2012
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myelomaJ T Larsen, S K Kumar, A Dispenzieri, et al.
Leukemia|September 6, 2013
Relationship between initial clinical presentation and the molecular cytogenetic classification of myelomaA J Greenberg, S V Rajkumar, T M Therneau, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Pediatrics|August 1, 1975
A chart audit peer review system in an ambulatory serviceR M Russo, V J Gururaj, T A Laude, et al.
Clinical Pediatrics|February 1, 1976
Triacetyloleandomycin in streptococcal throat infections. A reappraisal of an older antibioticV J Gururaj, R M Russo, S V Rajkumar, et al.
Leukemia|January 20, 2009
Dexamethasone and the risk for adrenal suppression in multiple myelomaA C Ng, S K Kumar, S J Russell, et al.
Leukemia|November 2, 2007
Clinically relevant end points and new drug approvals for myelomaK C Anderson, R A Kyle, S V Rajkumar, et al.
International Journal of Laboratory Hematology|April 5, 2012
A novel β-globin gene mutation HBB.c.22 G>C produces a hemoglobin variant (Hb Vellore) mimicking HbS in HPLCE S Edison, M Sathya, S V Rajkumar, et al.
British Journal of Haematology|September 16, 2009
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trialMorie A Gertz, Rafat Abonour, Leonard T Heffner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2013
Fluorescent PCR-based gene dose analysis for detection of deletion mutations in carriers of haemophiliaG Sankari Devi, N Arora, S V Rajkumar, et al.
Leukemia|February 6, 2013
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patientsL E Roeker, D R Larson, R A Kyle, et al.
Leukemia|November 28, 2012
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myelomaJ T Larsen, S K Kumar, A Dispenzieri, et al.
Leukemia|September 6, 2013
Relationship between initial clinical presentation and the molecular cytogenetic classification of myelomaA J Greenberg, S V Rajkumar, T M Therneau, et al.
Pageof 18